TABLE 2.
Trends in PIM prevalence in people with diabetes and polypharmacy 2012–2016
| Age group | Year | Number of PIM (n, % within year) | At least 1 PIM (n, %) | |||||
|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | |||
| 45–64 years | 2012 | 3155 (63.1%) | 1379 (27.6%) | 366 (7.3%) | 87 (1.7) | 13 (0.3%) | 0 (0%) | 1845 (36.9%) |
| 2013 | 3143 (61.3%) | 1513 (29.5%) | 377 (7.4%) | 84 (1.6%) | 12 (0.2%) | 0 (0%) | 1986 (38.7%) | |
| 2014 | 3127 (61.1%) | 1526 (29.8%) | 362 (7.1%) | 93 (1.8%) | 9 (0.2%) | 0 (0%) | 1990 (38.9%) | |
| 2015 | 3114 (61.0%) | 1509 (29.6%) | 383 (7.5%) | 92 (1.8%) | 5 (0.1%) | 0 (0%) | 1989 (39.0%) | |
| 2016 | 2692 (62.2%) | 1233 (28.5%) | 304 (7%) | 91 (2.1%) | 8 (0.2%) | 1 (<0.1%) | 1637 (37.8%)* | |
| ≥65 years | 2012 | 7729 (72.0%) | 2544 (23.7%) | 412 (3.8%) | 46 (0.4%) | 2 (0.02%) | 0 (0%) | 3004 (28.0%) |
| 2013 | 8265 (73.0%) | 2563 (22.6%) | 433 (3.8%) | 56 (0.5%) | 4 (0.03%) | 1 (<0.1%) | 3057 (27.0%) | |
| 2014 | 8624 (73.6%) | 2590 (22.1%) | 467 (4%) | 41 (0.3%) | 0 (0%) | 0 (0%) | 3098 (26.4%) | |
| 2015 | 8817 (74.3%) | 2610 (22.0%) | 400 (3.4%) | 41 (0.3%) | 2 (0.02%) | 0 (0%) | 3053 (25.7%) | |
| 2016 | 7590 (75.1%) | 2160 (21.4%) | 326 (3.2%) | 32 (0.3%) | 0 (0%) | 0 (0%) | 2518 (24.9%)** | |
*
P‐value for quadratic trend <0.05,
**
P‐value for linear trend <0.001.